3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Motor Activity
6
Polycystic Ovary Syndrome
2
Obesity
2
Diabetes Mellitus
2
Stroke
1
Sedentary Behavior
1
Sarcoma
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Osteoporosis
1
Neoplasms
1
Multiple Endocrine Neoplasia Type 1
1
Lung Neoplasms
1
Limb-girdle muscular dystrophy, type 2C
1
Leukemia, Myeloid, Acute
1
Kidney Diseases
1
Insulin Resistance
1
Hypertension
1
Heart Failure
1
Frailty
1
Endometrial Neoplasms
1
Diabetes Mellitus, Type 2
1
Cardiovascular Diseases
1
Breast Neoplasms
1
Body Weight
1
Arthritis
1
Interventions
relacorilant
3
empagliflozin
1
Resistance Training
1
Pioglitazone
1
Metformin
1
Exercise
1
Dipeptidyl-Peptidase IV Inhibitors
1
Ascorbic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Diabetes Mellitus, Type 2
×
Resistance Training
×
Clear all
NCT00786019
2023-07-12
InsITE
University of Colorado, Denver
Phase NA
Completed
47 enrolled
22 charts